Global Genicular Nerve Denervation Market Growth 2026-2032
The global Genicular Nerve Denervation market size is predicted to grow from US$ 374 million in 2025 to US$ 1356 million in 2032; it is expected to grow at a CAGR of 20.6% from 2026 to 2032.
Genicular Nerve Denervation is a minimally invasive medical procedure designed to reduce chronic knee pain, typically in patients with osteoarthritis or persistent pain following knee surgeries, such as knee replacements. The procedure involves selectively interrupting the sensory nerves that transmit pain signals from the knee to the brain. This is achieved without affecting motor function, thereby preserving joint movement.
United States market for Genicular Nerve Denervation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Genicular Nerve Denervation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Genicular Nerve Denervation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Genicular Nerve Denervation players cover Boston Scientific, Stryker, Abbott, Avanos Medical (coolief), Cosman Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Genicular Nerve Denervation Industry Forecast? looks at past sales and reviews total world Genicular Nerve Denervation sales in 2025, providing a comprehensive analysis by region and market sector of projected Genicular Nerve Denervation sales for 2026 through 2032. With Genicular Nerve Denervation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genicular Nerve Denervation industry.
This Insight Report provides a comprehensive analysis of the global Genicular Nerve Denervation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genicular Nerve Denervation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Genicular Nerve Denervation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genicular Nerve Denervation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genicular Nerve Denervation.
This report presents a comprehensive overview, market shares, and growth opportunities of Genicular Nerve Denervation market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Genicular Nerve Denervation market?
What factors are driving Genicular Nerve Denervation market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Genicular Nerve Denervation market opportunities vary by end market size?
How does Genicular Nerve Denervation break out by Type, by Application?
Genicular Nerve Denervation is a minimally invasive medical procedure designed to reduce chronic knee pain, typically in patients with osteoarthritis or persistent pain following knee surgeries, such as knee replacements. The procedure involves selectively interrupting the sensory nerves that transmit pain signals from the knee to the brain. This is achieved without affecting motor function, thereby preserving joint movement.
United States market for Genicular Nerve Denervation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Genicular Nerve Denervation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Genicular Nerve Denervation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Genicular Nerve Denervation players cover Boston Scientific, Stryker, Abbott, Avanos Medical (coolief), Cosman Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Genicular Nerve Denervation Industry Forecast? looks at past sales and reviews total world Genicular Nerve Denervation sales in 2025, providing a comprehensive analysis by region and market sector of projected Genicular Nerve Denervation sales for 2026 through 2032. With Genicular Nerve Denervation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genicular Nerve Denervation industry.
This Insight Report provides a comprehensive analysis of the global Genicular Nerve Denervation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genicular Nerve Denervation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Genicular Nerve Denervation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genicular Nerve Denervation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genicular Nerve Denervation.
This report presents a comprehensive overview, market shares, and growth opportunities of Genicular Nerve Denervation market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Standard RFA
- Cooled RFA
- Others
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boston Scientific
- Stryker
- Abbott
- Avanos Medical (coolief)
- Cosman Medical
- Diros Technology
- Vantage MedTech
- STARmed America
- Beijing Neo Science
What is the 10-year outlook for the global Genicular Nerve Denervation market?
What factors are driving Genicular Nerve Denervation market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Genicular Nerve Denervation market opportunities vary by end market size?
How does Genicular Nerve Denervation break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genicular Nerve Denervation Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Genicular Nerve Denervation by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Genicular Nerve Denervation by Country/Region, 2021, 2025 & 2032
2.2 Genicular Nerve Denervation Segment by Type
2.2.1 Standard RFA
2.2.2 Cooled RFA
2.2.3 Others
2.2.4 Genicular Nerve Denervation Sales by Type
2.2.4.1 Global Genicular Nerve Denervation Sales Market Share by Type (2021-2026)
2.2.4.2 Global Genicular Nerve Denervation Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Genicular Nerve Denervation Sale Price by Type (2021-2026)
2.3 Genicular Nerve Denervation Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Genicular Nerve Denervation Sales by Application
2.3.3.1 Global Genicular Nerve Denervation Sale Market Share by Application (2021-2026)
2.3.3.2 Global Genicular Nerve Denervation Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Genicular Nerve Denervation Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Genicular Nerve Denervation Breakdown Data by Company
3.1.1 Global Genicular Nerve Denervation Annual Sales by Company (2021-2026)
3.1.2 Global Genicular Nerve Denervation Sales Market Share by Company (2021-2026)
3.2 Global Genicular Nerve Denervation Annual Revenue by Company (2021-2026)
3.2.1 Global Genicular Nerve Denervation Revenue by Company (2021-2026)
3.2.2 Global Genicular Nerve Denervation Revenue Market Share by Company (2021-2026)
3.3 Global Genicular Nerve Denervation Sale Price by Company
3.4 Key Manufacturers Genicular Nerve Denervation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Genicular Nerve Denervation Product Location Distribution
3.4.2 Players Genicular Nerve Denervation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GENICULAR NERVE DENERVATION BY GEOGRAPHIC REGION
4.1 World Historic Genicular Nerve Denervation Market Size by Geographic Region (2021-2026)
4.1.1 Global Genicular Nerve Denervation Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Genicular Nerve Denervation Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Genicular Nerve Denervation Market Size by Country/Region (2021-2026)
4.2.1 Global Genicular Nerve Denervation Annual Sales by Country/Region (2021-2026)
4.2.2 Global Genicular Nerve Denervation Annual Revenue by Country/Region (2021-2026)
4.3 Americas Genicular Nerve Denervation Sales Growth
4.4 APAC Genicular Nerve Denervation Sales Growth
4.5 Europe Genicular Nerve Denervation Sales Growth
4.6 Middle East & Africa Genicular Nerve Denervation Sales Growth
5 AMERICAS
5.1 Americas Genicular Nerve Denervation Sales by Country
5.1.1 Americas Genicular Nerve Denervation Sales by Country (2021-2026)
5.1.2 Americas Genicular Nerve Denervation Revenue by Country (2021-2026)
5.2 Americas Genicular Nerve Denervation Sales by Type (2021-2026)
5.3 Americas Genicular Nerve Denervation Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genicular Nerve Denervation Sales by Region
6.1.1 APAC Genicular Nerve Denervation Sales by Region (2021-2026)
6.1.2 APAC Genicular Nerve Denervation Revenue by Region (2021-2026)
6.2 APAC Genicular Nerve Denervation Sales by Type (2021-2026)
6.3 APAC Genicular Nerve Denervation Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Genicular Nerve Denervation by Country
7.1.1 Europe Genicular Nerve Denervation Sales by Country (2021-2026)
7.1.2 Europe Genicular Nerve Denervation Revenue by Country (2021-2026)
7.2 Europe Genicular Nerve Denervation Sales by Type (2021-2026)
7.3 Europe Genicular Nerve Denervation Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genicular Nerve Denervation by Country
8.1.1 Middle East & Africa Genicular Nerve Denervation Sales by Country (2021-2026)
8.1.2 Middle East & Africa Genicular Nerve Denervation Revenue by Country (2021-2026)
8.2 Middle East & Africa Genicular Nerve Denervation Sales by Type (2021-2026)
8.3 Middle East & Africa Genicular Nerve Denervation Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genicular Nerve Denervation
10.3 Manufacturing Process Analysis of Genicular Nerve Denervation
10.4 Industry Chain Structure of Genicular Nerve Denervation
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Genicular Nerve Denervation Distributors
11.3 Genicular Nerve Denervation Customer
12 WORLD FORECAST REVIEW FOR GENICULAR NERVE DENERVATION BY GEOGRAPHIC REGION
12.1 Global Genicular Nerve Denervation Market Size Forecast by Region
12.1.1 Global Genicular Nerve Denervation Forecast by Region (2027-2032)
12.1.2 Global Genicular Nerve Denervation Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Genicular Nerve Denervation Forecast by Type (2027-2032)
12.7 Global Genicular Nerve Denervation Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Genicular Nerve Denervation Product Portfolios and Specifications
13.1.3 Boston Scientific Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Stryker
13.2.1 Stryker Company Information
13.2.2 Stryker Genicular Nerve Denervation Product Portfolios and Specifications
13.2.3 Stryker Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Stryker Main Business Overview
13.2.5 Stryker Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Genicular Nerve Denervation Product Portfolios and Specifications
13.3.3 Abbott Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Avanos Medical (coolief)
13.4.1 Avanos Medical (coolief) Company Information
13.4.2 Avanos Medical (coolief) Genicular Nerve Denervation Product Portfolios and Specifications
13.4.3 Avanos Medical (coolief) Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Avanos Medical (coolief) Main Business Overview
13.4.5 Avanos Medical (coolief) Latest Developments
13.5 Cosman Medical
13.5.1 Cosman Medical Company Information
13.5.2 Cosman Medical Genicular Nerve Denervation Product Portfolios and Specifications
13.5.3 Cosman Medical Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cosman Medical Main Business Overview
13.5.5 Cosman Medical Latest Developments
13.6 Diros Technology
13.6.1 Diros Technology Company Information
13.6.2 Diros Technology Genicular Nerve Denervation Product Portfolios and Specifications
13.6.3 Diros Technology Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Diros Technology Main Business Overview
13.6.5 Diros Technology Latest Developments
13.7 Vantage MedTech
13.7.1 Vantage MedTech Company Information
13.7.2 Vantage MedTech Genicular Nerve Denervation Product Portfolios and Specifications
13.7.3 Vantage MedTech Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Vantage MedTech Main Business Overview
13.7.5 Vantage MedTech Latest Developments
13.8 STARmed America
13.8.1 STARmed America Company Information
13.8.2 STARmed America Genicular Nerve Denervation Product Portfolios and Specifications
13.8.3 STARmed America Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 STARmed America Main Business Overview
13.8.5 STARmed America Latest Developments
13.9 Beijing Neo Science
13.9.1 Beijing Neo Science Company Information
13.9.2 Beijing Neo Science Genicular Nerve Denervation Product Portfolios and Specifications
13.9.3 Beijing Neo Science Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Beijing Neo Science Main Business Overview
13.9.5 Beijing Neo Science Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genicular Nerve Denervation Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Genicular Nerve Denervation by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Genicular Nerve Denervation by Country/Region, 2021, 2025 & 2032
2.2 Genicular Nerve Denervation Segment by Type
2.2.1 Standard RFA
2.2.2 Cooled RFA
2.2.3 Others
2.2.4 Genicular Nerve Denervation Sales by Type
2.2.4.1 Global Genicular Nerve Denervation Sales Market Share by Type (2021-2026)
2.2.4.2 Global Genicular Nerve Denervation Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Genicular Nerve Denervation Sale Price by Type (2021-2026)
2.3 Genicular Nerve Denervation Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Genicular Nerve Denervation Sales by Application
2.3.3.1 Global Genicular Nerve Denervation Sale Market Share by Application (2021-2026)
2.3.3.2 Global Genicular Nerve Denervation Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Genicular Nerve Denervation Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Genicular Nerve Denervation Breakdown Data by Company
3.1.1 Global Genicular Nerve Denervation Annual Sales by Company (2021-2026)
3.1.2 Global Genicular Nerve Denervation Sales Market Share by Company (2021-2026)
3.2 Global Genicular Nerve Denervation Annual Revenue by Company (2021-2026)
3.2.1 Global Genicular Nerve Denervation Revenue by Company (2021-2026)
3.2.2 Global Genicular Nerve Denervation Revenue Market Share by Company (2021-2026)
3.3 Global Genicular Nerve Denervation Sale Price by Company
3.4 Key Manufacturers Genicular Nerve Denervation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Genicular Nerve Denervation Product Location Distribution
3.4.2 Players Genicular Nerve Denervation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GENICULAR NERVE DENERVATION BY GEOGRAPHIC REGION
4.1 World Historic Genicular Nerve Denervation Market Size by Geographic Region (2021-2026)
4.1.1 Global Genicular Nerve Denervation Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Genicular Nerve Denervation Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Genicular Nerve Denervation Market Size by Country/Region (2021-2026)
4.2.1 Global Genicular Nerve Denervation Annual Sales by Country/Region (2021-2026)
4.2.2 Global Genicular Nerve Denervation Annual Revenue by Country/Region (2021-2026)
4.3 Americas Genicular Nerve Denervation Sales Growth
4.4 APAC Genicular Nerve Denervation Sales Growth
4.5 Europe Genicular Nerve Denervation Sales Growth
4.6 Middle East & Africa Genicular Nerve Denervation Sales Growth
5 AMERICAS
5.1 Americas Genicular Nerve Denervation Sales by Country
5.1.1 Americas Genicular Nerve Denervation Sales by Country (2021-2026)
5.1.2 Americas Genicular Nerve Denervation Revenue by Country (2021-2026)
5.2 Americas Genicular Nerve Denervation Sales by Type (2021-2026)
5.3 Americas Genicular Nerve Denervation Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genicular Nerve Denervation Sales by Region
6.1.1 APAC Genicular Nerve Denervation Sales by Region (2021-2026)
6.1.2 APAC Genicular Nerve Denervation Revenue by Region (2021-2026)
6.2 APAC Genicular Nerve Denervation Sales by Type (2021-2026)
6.3 APAC Genicular Nerve Denervation Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Genicular Nerve Denervation by Country
7.1.1 Europe Genicular Nerve Denervation Sales by Country (2021-2026)
7.1.2 Europe Genicular Nerve Denervation Revenue by Country (2021-2026)
7.2 Europe Genicular Nerve Denervation Sales by Type (2021-2026)
7.3 Europe Genicular Nerve Denervation Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genicular Nerve Denervation by Country
8.1.1 Middle East & Africa Genicular Nerve Denervation Sales by Country (2021-2026)
8.1.2 Middle East & Africa Genicular Nerve Denervation Revenue by Country (2021-2026)
8.2 Middle East & Africa Genicular Nerve Denervation Sales by Type (2021-2026)
8.3 Middle East & Africa Genicular Nerve Denervation Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genicular Nerve Denervation
10.3 Manufacturing Process Analysis of Genicular Nerve Denervation
10.4 Industry Chain Structure of Genicular Nerve Denervation
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Genicular Nerve Denervation Distributors
11.3 Genicular Nerve Denervation Customer
12 WORLD FORECAST REVIEW FOR GENICULAR NERVE DENERVATION BY GEOGRAPHIC REGION
12.1 Global Genicular Nerve Denervation Market Size Forecast by Region
12.1.1 Global Genicular Nerve Denervation Forecast by Region (2027-2032)
12.1.2 Global Genicular Nerve Denervation Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Genicular Nerve Denervation Forecast by Type (2027-2032)
12.7 Global Genicular Nerve Denervation Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Genicular Nerve Denervation Product Portfolios and Specifications
13.1.3 Boston Scientific Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Stryker
13.2.1 Stryker Company Information
13.2.2 Stryker Genicular Nerve Denervation Product Portfolios and Specifications
13.2.3 Stryker Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Stryker Main Business Overview
13.2.5 Stryker Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Genicular Nerve Denervation Product Portfolios and Specifications
13.3.3 Abbott Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Avanos Medical (coolief)
13.4.1 Avanos Medical (coolief) Company Information
13.4.2 Avanos Medical (coolief) Genicular Nerve Denervation Product Portfolios and Specifications
13.4.3 Avanos Medical (coolief) Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Avanos Medical (coolief) Main Business Overview
13.4.5 Avanos Medical (coolief) Latest Developments
13.5 Cosman Medical
13.5.1 Cosman Medical Company Information
13.5.2 Cosman Medical Genicular Nerve Denervation Product Portfolios and Specifications
13.5.3 Cosman Medical Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cosman Medical Main Business Overview
13.5.5 Cosman Medical Latest Developments
13.6 Diros Technology
13.6.1 Diros Technology Company Information
13.6.2 Diros Technology Genicular Nerve Denervation Product Portfolios and Specifications
13.6.3 Diros Technology Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Diros Technology Main Business Overview
13.6.5 Diros Technology Latest Developments
13.7 Vantage MedTech
13.7.1 Vantage MedTech Company Information
13.7.2 Vantage MedTech Genicular Nerve Denervation Product Portfolios and Specifications
13.7.3 Vantage MedTech Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Vantage MedTech Main Business Overview
13.7.5 Vantage MedTech Latest Developments
13.8 STARmed America
13.8.1 STARmed America Company Information
13.8.2 STARmed America Genicular Nerve Denervation Product Portfolios and Specifications
13.8.3 STARmed America Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 STARmed America Main Business Overview
13.8.5 STARmed America Latest Developments
13.9 Beijing Neo Science
13.9.1 Beijing Neo Science Company Information
13.9.2 Beijing Neo Science Genicular Nerve Denervation Product Portfolios and Specifications
13.9.3 Beijing Neo Science Genicular Nerve Denervation Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Beijing Neo Science Main Business Overview
13.9.5 Beijing Neo Science Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Genicular Nerve Denervation Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Genicular Nerve Denervation Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Standard RFA
Table 4. Major Players of Cooled RFA
Table 5. Major Players of Others
Table 6. Global Genicular Nerve Denervation Sales by Type (2021-2026) & (Units)
Table 7. Global Genicular Nerve Denervation Sales Market Share by Type (2021-2026)
Table 8. Global Genicular Nerve Denervation Revenue by Type (2021-2026) & ($ million)
Table 9. Global Genicular Nerve Denervation Revenue Market Share by Type (2021-2026)
Table 10. Global Genicular Nerve Denervation Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Genicular Nerve Denervation Sale by Application (2021-2026) & (Units)
Table 12. Global Genicular Nerve Denervation Sale Market Share by Application (2021-2026)
Table 13. Global Genicular Nerve Denervation Revenue by Application (2021-2026) & ($ million)
Table 14. Global Genicular Nerve Denervation Revenue Market Share by Application (2021-2026)
Table 15. Global Genicular Nerve Denervation Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Genicular Nerve Denervation Sales by Company (2021-2026) & (Units)
Table 17. Global Genicular Nerve Denervation Sales Market Share by Company (2021-2026)
Table 18. Global Genicular Nerve Denervation Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Genicular Nerve Denervation Revenue Market Share by Company (2021-2026)
Table 20. Global Genicular Nerve Denervation Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Genicular Nerve Denervation Producing Area Distribution and Sales Area
Table 22. Players Genicular Nerve Denervation Products Offered
Table 23. Genicular Nerve Denervation Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Genicular Nerve Denervation Sales by Geographic Region (2021-2026) & (Units)
Table 27. Global Genicular Nerve Denervation Sales Market Share Geographic Region (2021-2026)
Table 28. Global Genicular Nerve Denervation Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Genicular Nerve Denervation Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Genicular Nerve Denervation Sales by Country/Region (2021-2026) & (Units)
Table 31. Global Genicular Nerve Denervation Sales Market Share by Country/Region (2021-2026)
Table 32. Global Genicular Nerve Denervation Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Genicular Nerve Denervation Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Genicular Nerve Denervation Sales by Country (2021-2026) & (Units)
Table 35. Americas Genicular Nerve Denervation Sales Market Share by Country (2021-2026)
Table 36. Americas Genicular Nerve Denervation Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Genicular Nerve Denervation Sales by Type (2021-2026) & (Units)
Table 38. Americas Genicular Nerve Denervation Sales by Application (2021-2026) & (Units)
Table 39. APAC Genicular Nerve Denervation Sales by Region (2021-2026) & (Units)
Table 40. APAC Genicular Nerve Denervation Sales Market Share by Region (2021-2026)
Table 41. APAC Genicular Nerve Denervation Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Genicular Nerve Denervation Sales by Type (2021-2026) & (Units)
Table 43. APAC Genicular Nerve Denervation Sales by Application (2021-2026) & (Units)
Table 44. Europe Genicular Nerve Denervation Sales by Country (2021-2026) & (Units)
Table 45. Europe Genicular Nerve Denervation Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Genicular Nerve Denervation Sales by Type (2021-2026) & (Units)
Table 47. Europe Genicular Nerve Denervation Sales by Application (2021-2026) & (Units)
Table 48. Middle East & Africa Genicular Nerve Denervation Sales by Country (2021-2026) & (Units)
Table 49. Middle East & Africa Genicular Nerve Denervation Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Genicular Nerve Denervation Sales by Type (2021-2026) & (Units)
Table 51. Middle East & Africa Genicular Nerve Denervation Sales by Application (2021-2026) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of Genicular Nerve Denervation
Table 53. Key Market Challenges & Risks of Genicular Nerve Denervation
Table 54. Key Industry Trends of Genicular Nerve Denervation
Table 55. Genicular Nerve Denervation Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Genicular Nerve Denervation Distributors List
Table 58. Genicular Nerve Denervation Customer List
Table 59. Global Genicular Nerve Denervation Sales Forecast by Region (2027-2032) & (Units)
Table 60. Global Genicular Nerve Denervation Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Genicular Nerve Denervation Sales Forecast by Country (2027-2032) & (Units)
Table 62. Americas Genicular Nerve Denervation Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Genicular Nerve Denervation Sales Forecast by Region (2027-2032) & (Units)
Table 64. APAC Genicular Nerve Denervation Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Genicular Nerve Denervation Sales Forecast by Country (2027-2032) & (Units)
Table 66. Europe Genicular Nerve Denervation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Genicular Nerve Denervation Sales Forecast by Country (2027-2032) & (Units)
Table 68. Middle East & Africa Genicular Nerve Denervation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Genicular Nerve Denervation Sales Forecast by Type (2027-2032) & (Units)
Table 70. Global Genicular Nerve Denervation Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Genicular Nerve Denervation Sales Forecast by Application (2027-2032) & (Units)
Table 72. Global Genicular Nerve Denervation Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Boston Scientific Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 74. Boston Scientific Genicular Nerve Denervation Product Portfolios and Specifications
Table 75. Boston Scientific Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Boston Scientific Main Business
Table 77. Boston Scientific Latest Developments
Table 78. Stryker Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 79. Stryker Genicular Nerve Denervation Product Portfolios and Specifications
Table 80. Stryker Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Stryker Main Business
Table 82. Stryker Latest Developments
Table 83. Abbott Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 84. Abbott Genicular Nerve Denervation Product Portfolios and Specifications
Table 85. Abbott Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Abbott Main Business
Table 87. Abbott Latest Developments
Table 88. Avanos Medical (coolief) Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 89. Avanos Medical (coolief) Genicular Nerve Denervation Product Portfolios and Specifications
Table 90. Avanos Medical (coolief) Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Avanos Medical (coolief) Main Business
Table 92. Avanos Medical (coolief) Latest Developments
Table 93. Cosman Medical Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 94. Cosman Medical Genicular Nerve Denervation Product Portfolios and Specifications
Table 95. Cosman Medical Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Cosman Medical Main Business
Table 97. Cosman Medical Latest Developments
Table 98. Diros Technology Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 99. Diros Technology Genicular Nerve Denervation Product Portfolios and Specifications
Table 100. Diros Technology Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Diros Technology Main Business
Table 102. Diros Technology Latest Developments
Table 103. Vantage MedTech Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 104. Vantage MedTech Genicular Nerve Denervation Product Portfolios and Specifications
Table 105. Vantage MedTech Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Vantage MedTech Main Business
Table 107. Vantage MedTech Latest Developments
Table 108. STARmed America Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 109. STARmed America Genicular Nerve Denervation Product Portfolios and Specifications
Table 110. STARmed America Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. STARmed America Main Business
Table 112. STARmed America Latest Developments
Table 113. Beijing Neo Science Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 114. Beijing Neo Science Genicular Nerve Denervation Product Portfolios and Specifications
Table 115. Beijing Neo Science Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Beijing Neo Science Main Business
Table 117. Beijing Neo Science Latest Developments
Table 1. Genicular Nerve Denervation Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Genicular Nerve Denervation Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Standard RFA
Table 4. Major Players of Cooled RFA
Table 5. Major Players of Others
Table 6. Global Genicular Nerve Denervation Sales by Type (2021-2026) & (Units)
Table 7. Global Genicular Nerve Denervation Sales Market Share by Type (2021-2026)
Table 8. Global Genicular Nerve Denervation Revenue by Type (2021-2026) & ($ million)
Table 9. Global Genicular Nerve Denervation Revenue Market Share by Type (2021-2026)
Table 10. Global Genicular Nerve Denervation Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Genicular Nerve Denervation Sale by Application (2021-2026) & (Units)
Table 12. Global Genicular Nerve Denervation Sale Market Share by Application (2021-2026)
Table 13. Global Genicular Nerve Denervation Revenue by Application (2021-2026) & ($ million)
Table 14. Global Genicular Nerve Denervation Revenue Market Share by Application (2021-2026)
Table 15. Global Genicular Nerve Denervation Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Genicular Nerve Denervation Sales by Company (2021-2026) & (Units)
Table 17. Global Genicular Nerve Denervation Sales Market Share by Company (2021-2026)
Table 18. Global Genicular Nerve Denervation Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Genicular Nerve Denervation Revenue Market Share by Company (2021-2026)
Table 20. Global Genicular Nerve Denervation Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Genicular Nerve Denervation Producing Area Distribution and Sales Area
Table 22. Players Genicular Nerve Denervation Products Offered
Table 23. Genicular Nerve Denervation Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Genicular Nerve Denervation Sales by Geographic Region (2021-2026) & (Units)
Table 27. Global Genicular Nerve Denervation Sales Market Share Geographic Region (2021-2026)
Table 28. Global Genicular Nerve Denervation Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Genicular Nerve Denervation Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Genicular Nerve Denervation Sales by Country/Region (2021-2026) & (Units)
Table 31. Global Genicular Nerve Denervation Sales Market Share by Country/Region (2021-2026)
Table 32. Global Genicular Nerve Denervation Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Genicular Nerve Denervation Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Genicular Nerve Denervation Sales by Country (2021-2026) & (Units)
Table 35. Americas Genicular Nerve Denervation Sales Market Share by Country (2021-2026)
Table 36. Americas Genicular Nerve Denervation Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Genicular Nerve Denervation Sales by Type (2021-2026) & (Units)
Table 38. Americas Genicular Nerve Denervation Sales by Application (2021-2026) & (Units)
Table 39. APAC Genicular Nerve Denervation Sales by Region (2021-2026) & (Units)
Table 40. APAC Genicular Nerve Denervation Sales Market Share by Region (2021-2026)
Table 41. APAC Genicular Nerve Denervation Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Genicular Nerve Denervation Sales by Type (2021-2026) & (Units)
Table 43. APAC Genicular Nerve Denervation Sales by Application (2021-2026) & (Units)
Table 44. Europe Genicular Nerve Denervation Sales by Country (2021-2026) & (Units)
Table 45. Europe Genicular Nerve Denervation Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Genicular Nerve Denervation Sales by Type (2021-2026) & (Units)
Table 47. Europe Genicular Nerve Denervation Sales by Application (2021-2026) & (Units)
Table 48. Middle East & Africa Genicular Nerve Denervation Sales by Country (2021-2026) & (Units)
Table 49. Middle East & Africa Genicular Nerve Denervation Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Genicular Nerve Denervation Sales by Type (2021-2026) & (Units)
Table 51. Middle East & Africa Genicular Nerve Denervation Sales by Application (2021-2026) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of Genicular Nerve Denervation
Table 53. Key Market Challenges & Risks of Genicular Nerve Denervation
Table 54. Key Industry Trends of Genicular Nerve Denervation
Table 55. Genicular Nerve Denervation Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Genicular Nerve Denervation Distributors List
Table 58. Genicular Nerve Denervation Customer List
Table 59. Global Genicular Nerve Denervation Sales Forecast by Region (2027-2032) & (Units)
Table 60. Global Genicular Nerve Denervation Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Genicular Nerve Denervation Sales Forecast by Country (2027-2032) & (Units)
Table 62. Americas Genicular Nerve Denervation Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Genicular Nerve Denervation Sales Forecast by Region (2027-2032) & (Units)
Table 64. APAC Genicular Nerve Denervation Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Genicular Nerve Denervation Sales Forecast by Country (2027-2032) & (Units)
Table 66. Europe Genicular Nerve Denervation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Genicular Nerve Denervation Sales Forecast by Country (2027-2032) & (Units)
Table 68. Middle East & Africa Genicular Nerve Denervation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Genicular Nerve Denervation Sales Forecast by Type (2027-2032) & (Units)
Table 70. Global Genicular Nerve Denervation Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Genicular Nerve Denervation Sales Forecast by Application (2027-2032) & (Units)
Table 72. Global Genicular Nerve Denervation Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Boston Scientific Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 74. Boston Scientific Genicular Nerve Denervation Product Portfolios and Specifications
Table 75. Boston Scientific Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Boston Scientific Main Business
Table 77. Boston Scientific Latest Developments
Table 78. Stryker Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 79. Stryker Genicular Nerve Denervation Product Portfolios and Specifications
Table 80. Stryker Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Stryker Main Business
Table 82. Stryker Latest Developments
Table 83. Abbott Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 84. Abbott Genicular Nerve Denervation Product Portfolios and Specifications
Table 85. Abbott Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Abbott Main Business
Table 87. Abbott Latest Developments
Table 88. Avanos Medical (coolief) Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 89. Avanos Medical (coolief) Genicular Nerve Denervation Product Portfolios and Specifications
Table 90. Avanos Medical (coolief) Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Avanos Medical (coolief) Main Business
Table 92. Avanos Medical (coolief) Latest Developments
Table 93. Cosman Medical Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 94. Cosman Medical Genicular Nerve Denervation Product Portfolios and Specifications
Table 95. Cosman Medical Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Cosman Medical Main Business
Table 97. Cosman Medical Latest Developments
Table 98. Diros Technology Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 99. Diros Technology Genicular Nerve Denervation Product Portfolios and Specifications
Table 100. Diros Technology Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Diros Technology Main Business
Table 102. Diros Technology Latest Developments
Table 103. Vantage MedTech Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 104. Vantage MedTech Genicular Nerve Denervation Product Portfolios and Specifications
Table 105. Vantage MedTech Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Vantage MedTech Main Business
Table 107. Vantage MedTech Latest Developments
Table 108. STARmed America Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 109. STARmed America Genicular Nerve Denervation Product Portfolios and Specifications
Table 110. STARmed America Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. STARmed America Main Business
Table 112. STARmed America Latest Developments
Table 113. Beijing Neo Science Basic Information, Genicular Nerve Denervation Manufacturing Base, Sales Area and Its Competitors
Table 114. Beijing Neo Science Genicular Nerve Denervation Product Portfolios and Specifications
Table 115. Beijing Neo Science Genicular Nerve Denervation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Beijing Neo Science Main Business
Table 117. Beijing Neo Science Latest Developments
LIST OF FIGURES
Figure 1. Picture of Genicular Nerve Denervation
Figure 2. Genicular Nerve Denervation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genicular Nerve Denervation Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Genicular Nerve Denervation Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Genicular Nerve Denervation Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Genicular Nerve Denervation Sales Market Share by Country/Region (2025)
Figure 10. Genicular Nerve Denervation Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Standard RFA
Figure 12. Product Picture of Cooled RFA
Figure 13. Product Picture of Others
Figure 14. Global Genicular Nerve Denervation Sales Market Share by Type in 2026
Figure 15. Global Genicular Nerve Denervation Revenue Market Share by Type (2021-2026)
Figure 16. Genicular Nerve Denervation Consumed in Hospital
Figure 17. Global Genicular Nerve Denervation Market: Hospital (2021-2026) & (Units)
Figure 18. Genicular Nerve Denervation Consumed in Clinic
Figure 19. Global Genicular Nerve Denervation Market: Clinic (2021-2026) & (Units)
Figure 20. Global Genicular Nerve Denervation Sale Market Share by Application (2025)
Figure 21. Global Genicular Nerve Denervation Revenue Market Share by Application in 2026
Figure 22. Genicular Nerve Denervation Sales by Company in 2026 (Units)
Figure 23. Global Genicular Nerve Denervation Sales Market Share by Company in 2026
Figure 24. Genicular Nerve Denervation Revenue by Company in 2026 ($ millions)
Figure 25. Global Genicular Nerve Denervation Revenue Market Share by Company in 2026
Figure 26. Global Genicular Nerve Denervation Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Genicular Nerve Denervation Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Genicular Nerve Denervation Sales 2021-2026 (Units)
Figure 29. Americas Genicular Nerve Denervation Revenue 2021-2026 ($ millions)
Figure 30. APAC Genicular Nerve Denervation Sales 2021-2026 (Units)
Figure 31. APAC Genicular Nerve Denervation Revenue 2021-2026 ($ millions)
Figure 32. Europe Genicular Nerve Denervation Sales 2021-2026 (Units)
Figure 33. Europe Genicular Nerve Denervation Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Genicular Nerve Denervation Sales 2021-2026 (Units)
Figure 35. Middle East & Africa Genicular Nerve Denervation Revenue 2021-2026 ($ millions)
Figure 36. Americas Genicular Nerve Denervation Sales Market Share by Country in 2026
Figure 37. Americas Genicular Nerve Denervation Revenue Market Share by Country (2021-2026)
Figure 38. Americas Genicular Nerve Denervation Sales Market Share by Type (2021-2026)
Figure 39. Americas Genicular Nerve Denervation Sales Market Share by Application (2021-2026)
Figure 40. United States Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Genicular Nerve Denervation Sales Market Share by Region in 2026
Figure 45. APAC Genicular Nerve Denervation Revenue Market Share by Region (2021-2026)
Figure 46. APAC Genicular Nerve Denervation Sales Market Share by Type (2021-2026)
Figure 47. APAC Genicular Nerve Denervation Sales Market Share by Application (2021-2026)
Figure 48. China Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 52. India Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Genicular Nerve Denervation Sales Market Share by Country in 2026
Figure 56. Europe Genicular Nerve Denervation Revenue Market Share by Country (2021-2026)
Figure 57. Europe Genicular Nerve Denervation Sales Market Share by Type (2021-2026)
Figure 58. Europe Genicular Nerve Denervation Sales Market Share by Application (2021-2026)
Figure 59. Germany Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 60. France Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Genicular Nerve Denervation Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Genicular Nerve Denervation Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Genicular Nerve Denervation Sales Market Share by Application (2021-2026)
Figure 67. Egypt Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Genicular Nerve Denervation in 2026
Figure 73. Manufacturing Process Analysis of Genicular Nerve Denervation
Figure 74. Industry Chain Structure of Genicular Nerve Denervation
Figure 75. Channels of Distribution
Figure 76. Global Genicular Nerve Denervation Sales Market Forecast by Region (2027-2032)
Figure 77. Global Genicular Nerve Denervation Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Genicular Nerve Denervation Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Genicular Nerve Denervation Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Genicular Nerve Denervation Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Genicular Nerve Denervation Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Genicular Nerve Denervation
Figure 2. Genicular Nerve Denervation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genicular Nerve Denervation Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Genicular Nerve Denervation Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Genicular Nerve Denervation Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Genicular Nerve Denervation Sales Market Share by Country/Region (2025)
Figure 10. Genicular Nerve Denervation Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Standard RFA
Figure 12. Product Picture of Cooled RFA
Figure 13. Product Picture of Others
Figure 14. Global Genicular Nerve Denervation Sales Market Share by Type in 2026
Figure 15. Global Genicular Nerve Denervation Revenue Market Share by Type (2021-2026)
Figure 16. Genicular Nerve Denervation Consumed in Hospital
Figure 17. Global Genicular Nerve Denervation Market: Hospital (2021-2026) & (Units)
Figure 18. Genicular Nerve Denervation Consumed in Clinic
Figure 19. Global Genicular Nerve Denervation Market: Clinic (2021-2026) & (Units)
Figure 20. Global Genicular Nerve Denervation Sale Market Share by Application (2025)
Figure 21. Global Genicular Nerve Denervation Revenue Market Share by Application in 2026
Figure 22. Genicular Nerve Denervation Sales by Company in 2026 (Units)
Figure 23. Global Genicular Nerve Denervation Sales Market Share by Company in 2026
Figure 24. Genicular Nerve Denervation Revenue by Company in 2026 ($ millions)
Figure 25. Global Genicular Nerve Denervation Revenue Market Share by Company in 2026
Figure 26. Global Genicular Nerve Denervation Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Genicular Nerve Denervation Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Genicular Nerve Denervation Sales 2021-2026 (Units)
Figure 29. Americas Genicular Nerve Denervation Revenue 2021-2026 ($ millions)
Figure 30. APAC Genicular Nerve Denervation Sales 2021-2026 (Units)
Figure 31. APAC Genicular Nerve Denervation Revenue 2021-2026 ($ millions)
Figure 32. Europe Genicular Nerve Denervation Sales 2021-2026 (Units)
Figure 33. Europe Genicular Nerve Denervation Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Genicular Nerve Denervation Sales 2021-2026 (Units)
Figure 35. Middle East & Africa Genicular Nerve Denervation Revenue 2021-2026 ($ millions)
Figure 36. Americas Genicular Nerve Denervation Sales Market Share by Country in 2026
Figure 37. Americas Genicular Nerve Denervation Revenue Market Share by Country (2021-2026)
Figure 38. Americas Genicular Nerve Denervation Sales Market Share by Type (2021-2026)
Figure 39. Americas Genicular Nerve Denervation Sales Market Share by Application (2021-2026)
Figure 40. United States Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Genicular Nerve Denervation Sales Market Share by Region in 2026
Figure 45. APAC Genicular Nerve Denervation Revenue Market Share by Region (2021-2026)
Figure 46. APAC Genicular Nerve Denervation Sales Market Share by Type (2021-2026)
Figure 47. APAC Genicular Nerve Denervation Sales Market Share by Application (2021-2026)
Figure 48. China Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 52. India Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Genicular Nerve Denervation Sales Market Share by Country in 2026
Figure 56. Europe Genicular Nerve Denervation Revenue Market Share by Country (2021-2026)
Figure 57. Europe Genicular Nerve Denervation Sales Market Share by Type (2021-2026)
Figure 58. Europe Genicular Nerve Denervation Sales Market Share by Application (2021-2026)
Figure 59. Germany Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 60. France Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Genicular Nerve Denervation Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Genicular Nerve Denervation Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Genicular Nerve Denervation Sales Market Share by Application (2021-2026)
Figure 67. Egypt Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Genicular Nerve Denervation Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Genicular Nerve Denervation in 2026
Figure 73. Manufacturing Process Analysis of Genicular Nerve Denervation
Figure 74. Industry Chain Structure of Genicular Nerve Denervation
Figure 75. Channels of Distribution
Figure 76. Global Genicular Nerve Denervation Sales Market Forecast by Region (2027-2032)
Figure 77. Global Genicular Nerve Denervation Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Genicular Nerve Denervation Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Genicular Nerve Denervation Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Genicular Nerve Denervation Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Genicular Nerve Denervation Revenue Market Share Forecast by Application (2027-2032)
